Summary
Louis Mayaud is a technology leader and CTO with 14 years of experience translating biomedical research into regulated, market-ready medical devices and platforms. He holds a D.Phil. in Healthcare Innovation from Oxford and has combined clinical data science (MIMIC collaborations) with advanced algorithms like genetic optimization and Riemannian geometry to solve challenging physiological and neurofeedback problems. Louis led the NEWROFFED H2020 project and steered Mensia’s multi-center randomized trial and CE clearance for the first home-based ADHD medical device, and later guided US regulatory strategy and De Novo pathways. At Rhythm Diagnostic Systems he now directs innovation in vital sign monitoring, drawing on hands-on signal processing and cloud data architectures developed across prior roles. He pairs deep academic credibility and grant-raising experience with pragmatic product leadership, capable of taking prototypes through clinical validation and regulatory approval. An unusual strength is his track record of embedding cutting-edge mathematical models into real-time, medically certified consumer-facing systems.
14 years of coding experience
7 years of employment as a software developer
D.Phil. Healthcare Innovation, D.Phil. Healthcare Innovation at University of Oxford
M. Sc. 2 Signal and Image for Biology and Medecine, M. Sc. 2 Signal and Image for Biology and Medecine at Université d'Angers
Engineering Physics Electronics Computer Sciences, Engineering Physics Electronics Computer Sciences at Institut supérieur d'électronique et du numérique
Engineering Biotech, Engineering Biotech at Ecole superieure d'électronique de l'ouest
English, German